Escnx 5mg Tablet contains Escitalopram Oxalate, a selective serotonin reuptake inhibitor (SSRI) indicated for the treatment of major depressive disorder (MDD) and generalized anxiety disorder (GAD). Escitalopram functions by increasing the levels of serotonin, a neurotransmitter associated with mood regulation, in the brain, thereby helping to alleviate symptoms of depression and anxiety. The recommended dosage for adults typically begins at 5mg once daily, with adjustments made based on clinical response and tolerability, under medical supervision. Escnx 5mg is generally well tolerated; however, patients may experience side effects such as nausea, headache, insomnia, dry mouth, or dizziness. It is contraindicated in individuals with hypersensitivity to escitalopram or other SSRIs, and caution is advised when used concomitantly with monoamine oxidase inhibitors (MAOIs) or other serotonergic drugs due to the risk of serotonin syndrome. Escitalopram should be discontinued gradually to minimize withdrawal symptoms. Regular monitoring is recommended to assess therapeutic efficacy and detect any adverse reactions. Escnx 5mg Tablet should be used as part of a comprehensive treatment plan including psychological support when appropriate, and patients should be advised to report any worsening of symptoms or emergent suicidal ideation promptly.